entertainment -WSS

entertainment

author：entertainment 2025-10-02 21:36:00 - browse：8

The FDA building -- First Opinion coverage from STAT — Adobe

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine.

The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators. But in approving the drug for the treatment of fibrodysplasia ossificans progressiva, or FOP, the Food and Drug Administration concluded that Sohonos’ benefits outweigh its risks.

“I just closed my eyes and looked up to the skies, like ‘Thank you, God,’” said Suzanne Hollywood, whose teenage son, Joey, has been receiving the drug in a clinical trial. “It’s far from perfect, but I’m thrilled for my son, for his future, and for the kids getting diagnosed who might not have to experience what others had to.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout Newsletter: What happened with Sarepta's Duchenne data

WSS

CDC recommends rationing of RSV shot due to shortages

Meta's Zuckerberg and Chan on track to put $50 billion into science

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Meta's Zuckerberg and Chan on track to put $50 billion into science

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Eli Lilly to pay $200M for Beam’s stake in gene

Wikipedia

entertainment

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chimpanzees, like humans and whales, get menopause: Study

Drug repurposing or repositioning? The language matters

Readers respond to H5N1 and livestock movements, and more

BioMarin wins approval for gene therapy to treat hemophilia A

The FDA weighs the risks of candy

Novavax promises a turnaround & Lilly roils the obesity market

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Affirmative action in medical school literally saved lives

WHO may add ‘noma' to its list of neglected tropical diseases

focus

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

HIV vaccine remains elusive. Immunologists keep trying new ideas

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Chimpanzees, like humans and whales, get menopause: Study

Medtronic CEO on promising devices for diabetes, hypertension

Helping hospitals and community health centers plan for resilience

knowledge

focus

hotspot

hotspot